Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
Circulation. Cardiovascular Imaging|November 19, 2024
Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With AlirocumabKonstantinos C Koskinas, Jonas Häner, Yasushi Ueki, et al.
JACC. Cardiovascular Interventions|April 12, 2023
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT TrialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Lancet (London, England)|September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Journal of the American Heart Association|March 1, 2022
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS TrialFelice Gragnano, Marcel Zwahlen, Pascal Vranckx, et al.
American Heart Journal|August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCIRaffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: a prespecified analysis from the MASTER DAPT trialAntonio Landi, Felix Mahfoud, Enrico Frigoli, et al.
European Heart Journal|March 23, 2017
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevationPascal Vranckx, Enrico Frigoli, Martina Rothenbühler, et al.
European Heart Journal|November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromesRoland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
European Heart Journal|May 17, 2022
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Pieter C Smits, Enrico Frigoli, et al.
Pageof 30